Segment Reporting (Tables)

3 Months Ended

Mar. 31, 2025

Segment Reporting [Abstract]

Schedule of Segment Loss, Including Significant Segment Expenses

The table below is a summary of the segment loss, including significant segment expenses:

	Three Months Ended March 31,
	2025			2024
Revenues	$	—		$	—
Research and development expenses:
LTI-01 program-related expenses:
CMC activities		537			1,420
Clinical operation activities		65			43
Total LTI-01 program-related expenses		602			1,463
LTI-03 program-related expenses:
Preclinical study costs		556			82
CMC activities		560			260
Clinical operation activities		673			1,031
Total LTI-03 program-related expenses		1,789			1,373
Other program-related expenses		8			39
Employee related expenses		622			606
Professional fees for services		17			(20	)
Facilities and other expenses		16			2
Total research and development expenses		3,054			3,463
General and administrative expenses:
Employee related expenses		947			1,200
Professional fees for services		1,138			2,000
Facilities and other expenses		470			542
Total general and administrative expenses		2,555			3,742
Other income, net		(108	)		(92	)
Segment and consolidated net loss	$	(5,501	)	$	(7,113	)